CVI Holdings’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

CVI Holdings’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-247,578	Closed	-$20K	–	951
2022 Q2	$20K	Hold	247,578	–	–	﹤0.01%	641
2022 Q1	$36K	Sell	247,578 -16,829	-6%	-$3.05K	﹤0.01%	678
2021 Q4	$77K	Sell	264,407 -208,711	-44%	-$107K	0.01%	687
2021 Q3	$355K	Buy	473,118 +73,118	+18%	+$55.1K	0.02%	467
2021 Q2	$300K	Hold	400,000	–	–	0.02%	434
2021 Q1	$218K	Buy	+400,000	New	+$320K	0.02%	414

Other funds holding CRXTW

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

CVI Holdings's CRXTW Position: Q3 2022 in Review

CVI Holdings sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q3 2022, closing a stake of 247,578 shares — an estimated $20K sold.

CVI Holdings first reported a position in CRXTW in Q1 2021 and held it in 6 quarters. The position peaked at $355K in Q3 2021. 5 funds tracked by Wall St. Rank hold CRXTW as of Q3 2022.

CVI Holdings reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
CVI Holdings sold 247,578 Clarus Therapeutics Holdings, Inc. Warrants shares in Q3 2022, an estimated $20K.
CVI Holdings first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q1 2021 and held it in 6 quarters.
CVI Holdings's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $355K in Q3 2021.
5 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q3 2022.

Based on CVI Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.